Azelastine

Chemical formula: C₂₂H₂₄ClN₃O  Molecular mass: 381.898 g/mol  PubChem compound: 2267

Therapeutic indications

Azelastine is indicated for:

Seasonal allergic conjunctivitis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Treatment and prevention of the symptoms of seasonal allergic conjunctivitis in adults and children 4 years and older.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Seasonal allergic rhinitis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Azelastine is indicated for the treatment of both seasonal allergic rhinitis (e.g. hay fever) and perennial allergic rhinitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Non-seasonal (perennial) allergic conjunctivitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Treatment of the symptoms of non-seasonal (perennial) allergic conjunctivitis in adults and children 12 years and older.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.